Showing 41 - 60 results of 141 for search '"ImmunoTargets and Therapy"', query time: 0.79s Refine Results
  1. 41
    Clinical potential of apremilast in the treatment of psoriatic arthritis

    Clinical potential of apremilast in the treatment of psoriatic arthritis by Cauli A, Porru G, Piga M, Vacca A, Dessole G, Mathieu A

    Published 2014-06-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  2. 42
    Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology

    Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology by Unterberger S, Davies KA, Rambhatla SB, Sacre S

    Published 2021-07-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  3. 43
    Immunotherapy of Multiple Myeloma: Promise and Challenges

    Immunotherapy of Multiple Myeloma: Promise and Challenges by Abramson HN

    Published 2021-09-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  4. 44
    Therapeutic vaccines in non-small cell lung cancer

    Therapeutic vaccines in non-small cell lung cancer by Socola F, Scherfenberg N, Raez LE

    Published 2013-09-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  5. 45
    Targeting IL-4 for the Treatment of Atopic Dermatitis

    Targeting IL-4 for the Treatment of Atopic Dermatitis by Chiricozzi A, Maurelli M, Peris K, Girolomoni G

    Published 2020-09-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  6. 46
    NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

    NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer by Huang Q, Cao H, Yao Q, Zhou X, Li H, Bai Q, Hu H

    Published 2023-12-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  7. 47
    CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer

    CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer by Li Y, Gu Y, Yang P, Wang Y, Yu X, Li Y, Jin Z, Xu L

    Published 2024-01-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  8. 48
    William Bradley Coley, MD, and the phenomenon of spontaneous regression

    William Bradley Coley, MD, and the phenomenon of spontaneous regression by Vernon LF

    Published 2018-04-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  9. 49
    Immunotherapy in the management of melanoma: current status

    Immunotherapy in the management of melanoma: current status by Alston D, Brewer JD

    Published 2013-02-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  10. 50
    Cannabidiol as a Novel Therapeutic for Immune Modulation

    Cannabidiol as a Novel Therapeutic for Immune Modulation by Peyravian N, Deo S, Daunert S, Jimenez JJ

    Published 2020-08-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  11. 51
    Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study

    Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study by Zhang H, Xu A, Li X, Pan B, Wan X

    Published 2024-04-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  12. 52
    Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis

    Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability T... by Zhao J, Hao S, Li Y, Liu X, Liu Z, Zheng C, Han D

    Published 2023-11-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  13. 53
    Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy

    Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy by Drakes ML, Stiff PJ

    Published 2014-12-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  14. 54
    Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma

    Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma by Sepe P, Mennitto A, Corti F, Procopio G

    Published 2020-11-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  15. 55
    Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer

    Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer by Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L

    Published 2023-01-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  16. 56
    Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

    Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis by Atzeni F, Carriero A, Boccassini L, D'Angelo S

    Published 2021-05-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  17. 57
    Novel Resolution Mediators of Severe Systemic Inflammation

    Novel Resolution Mediators of Severe Systemic Inflammation by Gudernatsch V, Stefańczyk SA, Mirakaj V

    Published 2020-03-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  18. 58
    Update on immunopathogenesis and immunotherapy in multiple sclerosis

    Update on immunopathogenesis and immunotherapy in multiple sclerosis by Selter RC, Hemmer B

    Published 2013-04-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  19. 59
    Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?

    Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators? by Li J, Bao G, Wang H

    Published 2020-10-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  20. 60
    Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy

    Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy by Perna SK, Huye LE, Savoldo B

    Published 2015-03-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article

Search Tools: